Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
1.910
-0.020 (-1.04%)
At close: Dec 8, 2025, 4:00 PM EST
1.870
-0.040 (-2.07%)
Pre-market: Dec 9, 2025, 8:48 AM EST
Venus Concept Market Cap
Venus Concept has a market cap or net worth of $3.55 million as of December 9, 2025. Its market cap has increased by 56.87% in one year.
Market Cap
3.55M
Enterprise Value
31.90M
1-Year Change
56.87%
Ranking
Category
Stock Price
$1.91
Market Cap Chart
Since November 8, 2019, Venus Concept's market cap has decreased from $154.44M to $3.55M, a decrease of -97.70%. That is a compound annual growth rate of -46.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.59M | 31.36% |
| Dec 31, 2024 | 2.73M | -58.13% |
| Dec 29, 2023 | 6.52M | -72.40% |
| Dec 30, 2022 | 23.64M | -74.33% |
| Dec 31, 2021 | 92.08M | 1.60% |
| Dec 31, 2020 | 90.62M | -35.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |